Cargando…
ER Stress in COVID-19 and Parkinson’s Disease: In Vitro and In Silico Evidences
The outbreak of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) signifies a serious worldwide concern to public health. Both transcriptome and proteome of SARS-CoV-2-infected cells synergize the progression of infection in host, which may exacerbate symptoms and/or pr...
Autores principales: | Chaudhry, Zahara L., Gamal, Mahmoud, Ferhati, Ingrid, Warda, Mohamad, Ahmed, Bushra Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025812/ https://www.ncbi.nlm.nih.gov/pubmed/35448038 http://dx.doi.org/10.3390/brainsci12040507 |
Ejemplares similares
-
COVID-19 and Parkinson’s Disease: Shared Inflammatory Pathways Under Oxidative Stress †
por: Chaudhry, Zahara L., et al.
Publicado: (2020) -
In-vitro and in-silico evidence for oxidative stress as drivers for RDW
por: Joosse, Huibert-Jan, et al.
Publicado: (2023) -
Real-time detection and continuous monitoring of ER stress in vitro and in vivo by ES-TRAP: evidence for systemic, transient ER stress during endotoxemia
por: Hiramatsu, Nobuhiko, et al.
Publicado: (2006) -
P1500: WHAT’S DRIVING RDW? IN-VITRO AND IN-SILICO EVIDENCE FOR OXIDATIVE STRESS
por: Joosse, Huibert-Jan, et al.
Publicado: (2023) -
TRPV4 contributes to ER stress and inflammation: implications for Parkinson’s disease
por: Liu, Na, et al.
Publicado: (2022)